Science Highlights 2023: Central Nervous System Cancer
This session highlights the most clinically relevant abstracts within the Central Nervous System track of the 2023 ASTRO Annual Meeting scientific program.
Category
  • Central Nervous System
Format
  • Science Highlights
  • CME only
Credits
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Certificate of Attendance
Radiation-Induced Sensorineural Hearing Loss and Potential Management
This is a review of causes and treatment of sensorineural hearing loss after radiation therapy.
Category
  • Other
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Advancement in Imaging for Radiation Oncology
Various advances in imaging are changing the clinical practice for Radiation Oncology.
Category
  • Other
  • Physics
  • Genitourinary Cancer
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Combined Modality Therapy for Lymph Node Positive Prostate Cancer
Historically, the management of lymph node positive prostate cancer was limited to androgen deprivation therapy, but increasing data now support the use of multimodality therapy. As treatment options have expanded, patient-centered decision making has become increasingly complicated.
Category
  • Genitourinary Cancer
Format
  • CME only
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Anal Cancer: Across the Spectrum of Care
Anal cancer rates are increasing, and there is a need to improve coordination across the spectrum of anal cancer care, from diagnosis, treatment, recovery and survivorship. Failure to understand the roles of all the multidisciplinary aspects of care leads to suboptimal patient care.  
Category
  • Other
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Gray Zone - Cervical Cancer with Vaginal Recurrence and Prior Pelvic Radiation
The ultimate goal of radiation oncology research is to improve clinical care.  As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.  But despite our best efforts, evidence-based medicine cannot provide 1 clear
Category
  • Gynecologic Cancer
Format
  • Gray Zone
Credits
  • 1.00 AMA PRA Category 1 Credit™
Challenging Cases in Patient Safety: The Nation’s Experience Navigating New Technologies as Told to RO-ILS
When implementing newer technologies practices often rely on vendor training, an evaluation of published literature, and collaboration with others experienced in the technology. Incident learning has a critical role in radiation therapy and may be most important in new and emerging technologies.
Category
  • Non Clinical Skills
  • Other
  • Patient Safety
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
DEIinRO Webinar - Sexual and Gender Identity (SGM)-Based Microaggressions: Recognizing and Responding to Bias in Healthcare
Live Webinar
Category
  • Non Clinical Skills
Format
  • Webinars
Credits
Oligometastatic Breast Cancer: Considering Patients One by One
SBRT for oligometastatic disease of mixed histologies has been shown to improve progression-free and even overall survival. A large cooperative group study recently demonstrated that there was no overall survival advantage seen when constrained to breast cancer alone.
Category
  • SBRT
  • Breast Cancer
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Stereotactic Radiotherapy and Renal Cell Cancer: Overcoming Radioresistance and the Resistance to Radiate
The use of SABR is well established in many cancers, however, its application within kidney cancer is relatively new. This is largely due to the historical notion that renal cell carcinoma (RCC) is highly radioresistant.
Category
  • Other
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance

Pages